Crohn's & Colitis Foundation Executive and Leadership Team

Sharon Lungrin, the Chief Operating Officer at Crohn's & Colitis Foundation, directs the operational framework supporting the organization's mission to cure Crohn's disease and ulcerative colitis. Overseeing day-to-day activities, Lungrin ensures efficient resource allocation and the seamless execution of strategic initiatives across all departments. This leadership role involves optimizing internal processes to maximize the foundation's impact on patient quality of life and research advancement. By streamlining operational workflows, Sharon Lungrin directly contributes to the foundation's capacity to fund critical research and provide essential support services. The Chief Operating Officer's focus remains on enhancing organizational effectiveness and scalability to meet the growing needs of the patient community.

Chris Adams, the Northwest Chapter Board President at Crohn's & Colitis Foundation, leads regional governance and community engagement efforts to advance the organization's mission. Adams oversees the strategic direction and operational oversight for the Northwest chapter, ensuring alignment with national objectives for curing Crohn's disease and ulcerative colitis. This leadership position involves fostering strong relationships with local stakeholders, volunteers, and donors to amplify the foundation's impact. By championing patient advocacy and fundraising initiatives within the region, Chris Adams directly supports critical research and patient support programs. The Northwest Chapter Board President's dedication ensures robust local support for the foundation's vital work across the United States.

Stephanie Brock, the President of the Board of Directors at Crohn's & Colitis Foundation, provides strategic oversight and governance to guide the organization's mission. Brock leads the board in setting the long-term vision and ensuring financial stewardship necessary to find cures for Crohn's disease and ulcerative colitis. This pivotal role involves collaborating with executive leadership to uphold the foundation's commitment to improving the quality of life for affected individuals. By ensuring accountability and strategic alignment, Stephanie Brock drives the organization's progress toward its ambitious goals. The President of the Board of Directors' leadership is fundamental to the foundation's sustained success and its ability to make a profound difference in the lives of patients.

Traxx Traxx, the President at Crohn's & Colitis Foundation, directs the overall strategic vision and operational execution of the organization's core objectives. Traxx leads efforts to accelerate the search for cures for Crohn's disease and ulcerative colitis, while simultaneously enhancing the quality of life for patients. This executive position involves fostering collaboration across all functional areas to maximize the foundation's impact and reach. By guiding key initiatives and ensuring alignment with the mission, Traxx Traxx plays a crucial role in advancing patient care and scientific research. The President's leadership is instrumental in driving the foundation's progress and achieving its critical goals for the patient community.

Jeffrey Mittleman, the President of the Board of Trustees at Crohn's & Colitis Foundation, provides high-level governance and strategic direction for the organization's long-term objectives. Mittleman leads the board in upholding fiduciary responsibilities and ensuring the foundation's resources are effectively deployed to find cures for Crohn's disease and ulcerative colitis. This leadership role is critical in maintaining the integrity and impact of the foundation's work, focusing on improving patient outcomes and supporting groundbreaking research. By guiding the board's strategic decisions, Jeffrey Mittleman ensures sustained progress toward alleviating the burden of these diseases. The President of the Board of Trustees' oversight is essential for the foundation's continued success and its commitment to the patient community.

Rohit Suri, the Chief Technology Officer at Crohn's & Colitis Foundation, architects the technological infrastructure vital for advancing the organization's goals. Suri drives the development and implementation of innovative digital solutions that enhance research capabilities, improve patient engagement, and support fundraising efforts. This critical role involves leveraging technology to expand the foundation's reach and accelerate the search for cures for Crohn's disease and ulcerative colitis. By ensuring robust data management and secure digital platforms, Rohit Suri safeguards sensitive information and facilitates seamless collaboration among researchers and stakeholders. The Chief Technology Officer's strategic vision ensures that technology serves as a powerful engine for progress in patient care and scientific discovery.

Orna Ehrlich, the Chief of Staff and Impact at Crohn's & Colitis Foundation, orchestrates strategic initiatives and measures the organization's effectiveness in achieving its mission. Ehrlich ensures alignment between operational activities and the overarching goals of finding cures for Crohn's disease and ulcerative colitis. This position involves close collaboration with executive leadership to drive key projects and enhance the foundation's societal impact. By analyzing program outcomes and identifying areas for improvement, Orna Ehrlich directly contributes to maximizing the foundation's effectiveness in serving patients and advancing research. The Chief of Staff and Impact role is central to translating strategic objectives into tangible results that improve the quality of life for those affected by these chronic conditions.